Enovis Corporation ENOV 深 滬
已收盤 02-06 16:00:00 美东时间
22.59
+0.800
+3.67%
華盛通- 最 高22.70
- 今 開21.94
- 成交量 84.68万股
- 最 低 21.74
- 昨 收 21.79
- 總市值 12.92亿
- 52周最高 44.755
- 市盈率 靜 --
- 換手率 1.48%
- 52周最低 21.00
- 委 比 20.72%
- 總股本 5718.94万
- 歷史最高 176.11
- 量 比 0.67
- 振 幅 4.41%
- 歷史最低 -13.31
- 每 手 1
- 風險率 4.89%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Enovis nimmt an der BTIG MedTech-Konferenz teil
Enovis nimmt an der BTIG MedTech-Konferenz teil Enovis Corporation wird am Mittwoch, den 11. Februar 2026, an der BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah teilnehmen. Disclaimer: This news brief was created by Public Technologies (PUBT) u
02-03 21:01
Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
<p>Enovis Corporation has announced that its management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 11, 2026, in Snowbird, UT. The company, a global medical technology innovator, focuses on developing solutions to improve patient outcomes and restore motion. More information is available on their website, www.enovis.com, and investors are encouraged to review updates on ...
02-03 13:00
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
Enovis Corporation will host an investor conference call and live webcast on February 26, 2026, at 8:30 a.m. Eastern Time to discuss its 2025 fourth quarter and full year financial results. The event will also include a presentation accessible via the "Investors" section of Enovis' website. Investors can join the call by dialing (833) 685-0901 (U.S.) or (412) 317-5715 (International). A replay will be available later that day on the company's web...
01-23 13:30
Top 3 Health Care Stocks That Could Blast Off This Month
The most oversold stocks in the health care sector presents an opportunity to b...
01-21 19:41
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
BTIG Initiates Coverage On Enovis with Buy Rating, Announces Price Target of $41
BTIG analyst Ryan Zimmerman initiates coverage on Enovis (NYSE:ENOV) with a Buy rating and announces Price Target of $41.
01-06 19:31
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
Freedom Capital Markets Initiates Coverage On Enovis with Buy Rating, Announces Price Target of $45
Freedom Capital Markets analyst Keith Hinton initiates coverage on Enovis (NYSE:ENOV) with a Buy rating and announces Price Target of $45.
2025-12-17 17:19
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
